Not in the classic sense. Pooled studies find people with fibromyalgia have slightly higher levels of some inflammation signals, such as IL-6 and TNF-alpha, but the differences are small and not specific to fibromyalgia. Anti-inflammatory painkillers did no better than placebo in trials. Exercise is the best-supported treatment.
Pain everywhere, blood tests that look fine
Fibromyalgia is long-lasting pain across the body, along with tiredness, poor sleep and trouble thinking clearly. It affects an estimated 1.78% of people worldwide, mostly women.
Here is the frustrating part. There is still no blood test or scan that confirms it. So people hear "your tests look normal" while they hurt every day. That gap is why the question of inflammation matters so much. If something in the blood ran high, it could prove the pain is real and point to a treatment.
Inflammation is your immune system's response to injury or threat. Doctors track it with signaling proteins in the blood called cytokines. Two common ones are IL-6 and TNF-alpha. Another marker, CRP (C-reactive protein), is made by the liver when inflammation is going on.
What do inflammation markers in fibromyalgia show?
Three large reviews have pooled the blood studies. A meta-analysis combines the results of many studies into one estimate.
Bias would normally make the pills look better. No benefit showed up anyway.From a 2017 systematic review in Cochrane Database Syst Rev
A 2020 meta-analysis pooled 29 studies comparing people with fibromyalgia to healthy people. IL-6 and two other signals, IL-4 and IL-17A, were higher in fibromyalgia. The authors called the effect sizes "small-to-moderate." They also found very high differences between studies, partly explained by sex, the time of day blood was drawn, whether people paused their medicines, and whether people with major depression were left out.
A 2021 meta-analysis of 22 studies with 1,772 people found higher TNF-alpha, IL-6 and IL-8. But IL-10, a signal that calms inflammation, was also higher. So the pattern is a mix, not a simple fire alarm. One signal stood out across studies: eotaxin, a chemical messenger that draws certain immune cells, was consistently raised.
The largest review, from 2022, meta-analyzed 40 studies. People with fibromyalgia had higher IL-6, IL-8, TNF-alpha, interferon gamma and CRP than healthy people. Its conclusion was careful: none of these markers could be called a specific marker of fibromyalgia. Some may instead flag other conditions that often come along with it.
That last point matters. In a 2021 review of 41 studies, 35.7% of people with fibromyalgia had obesity. Other conditions travel with fibromyalgia too. So when a marker runs a little high, the fibromyalgia may not be the reason.
Why anti-inflammatory pills don't help much
If fibromyalgia were driven by inflammation the way rheumatoid arthritis is, anti-inflammatory drugs should ease it. They don't seem to.
A 2017 Cochrane review found six randomized trials of NSAIDs (the drug group that includes ibuprofen and naproxen), with 292 people. Across the analyses, there was no significant difference between the pills and placebo. The evidence was very low quality, but the reviewers noted that bias usually makes drugs look better, and still no benefit showed up. They concluded NSAIDs "cannot be regarded as useful" for fibromyalgia.
Is the inflammation in the nerves or the brain?
The more interesting clues are in the nervous system.
A 2019 meta-analysis pulled together 8 studies of 222 people. About 49% had small fiber pathology: changes in the thinnest nerve fibers, found with a skin biopsy or an eye scan. The authors called it evidence of "a distinct phenotype," meaning a subgroup of patients.
A 2019 brain scan study compared 31 people with fibromyalgia to 27 healthy people. It found widespread signs of activated glial cells, the brain's own immune cells, in the outer layer of the brain. The authors called it the first direct evidence in living people that these cells play a role. This is a single study of 58 people, so it is an early clue rather than an answer.
So "inflammatory" may be the right word for some of what happens in fibromyalgia, just not in the joints or the blood where most people look.
Does exercise calm fibromyalgia inflammation?
We don't know yet. A review of 6 studies on single workouts found that people with fibromyalgia "probably have low-grade chronic inflammation," but the effect of exercise on those markers was unclear. None of the studies reported that exercise made symptoms worse.
What is clear is that exercise helps the pain. In the 2017 European guidelines, built from 107 reviews, exercise was the only treatment to earn a "strong for" recommendation. A 2025 meta-analysis of 17 trials found aerobic exercise lowered pain.
What this means for you
Tick what you'll try this week. Your picks stay on this device.
you have swollen, hot or red joints, morning stiffness that lasts a long time, fevers, rashes or weight loss you can't explain (signs of a different inflammatory disease); you have heart, lung or joint problems before starting exercise; or you take painkillers most days.
One tap. Results appear once 50 readers have voted, and the count is always real.
The bottom line
Blood markers that nudge up but can't name the illness. Painkillers that fight inflammation and don't touch the pain. Nerve fibers changed in about half of patients, and immune cells stirring in the brain. Put together, the evidence says fibromyalgia is not an inflammatory disease in the way arthritis is. Inflammation may still be part of the story, in a quieter place. While science works that out, the treatment with the strongest proof is the plainest one: move a little, and build from there.
Common questions
Does fibromyalgia cause inflammation in the body?
Not in a clear, measurable way. Meta-analyses found slightly higher IL-6, TNF-alpha and CRP in people with fibromyalgia, but the differences were small and the studies varied a lot. These markers are not specific to fibromyalgia, and other conditions that often come with it, like obesity, may explain part of the rise.
What inflammation markers are high in fibromyalgia?
The most repeated ones are IL-6, IL-8 and TNF-alpha, with CRP higher in one large review. Eotaxin was consistently raised across studies. But IL-10, which calms inflammation, was also higher, and IL-1 beta was lower. That mixed picture is why no marker can diagnose fibromyalgia yet.
Is there a fibromyalgia anti-inflammatory diet?
Not one with solid proof. A 2020 review of 22 studies, including 18 randomized trials, tested 17 different diets and supplements. Some small trials of vegan and low-FODMAP diets reported less pain, but the studies were small and often poor quality. The authors found not enough evidence to recommend any one diet.
Ask the Research Desk
Heard something about inflammation you want checked? The best questions become articles, credited by first name only if you say yes.
How this article was made
Researched and written from 11 peer-reviewed papers. Our automated check matched every claim against the exact words of its source, confirmed every paper exists in PubMed, and found none retracted. Checked October 31, 2026. Not individually reviewed by a doctor. Photos are illustrative; the people in them are not patients or readers.
Grades run Strong, Moderate, Emerging, Early and Not supported, and the grade decides the words we may use. How we grade evidence · Medical disclaimer
Sources
- Meta-analysisPeripheral immune aberrations in fibromyalgia: A systematic review, meta-analysis and meta-regression.Andrés-Rodríguez L, Borràs X, Feliu-Soler A et al. Brain Behav Immun, 2020.PubMedFull paper
- Meta-analysisIs fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis.O'Mahony LF, Srivastava A, Mehta P et al. Rheumatology (Oxford), 2021.PubMedFull paper
- Meta-analysisPotential role of blood biomarkers in patients with fibromyalgia: a systematic review with meta-analysis.Kumbhare D, Hassan S, Diep D et al. Pain, 2022.PubMedFull paper
- Meta-analysisA systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: Implications for a new paradigm in fibromyalgia etiopathogenesis.Grayston R, Czanner G, Elhadd K et al. Semin Arthritis Rheum, 2019.PubMedFull paper
- Systematic reviewEULAR revised recommendations for the management of fibromyalgia.Macfarlane GJ, Kronisch C, Dean LE et al. Ann Rheum Dis, 2017.PubMedFull paper
- StudyBrain glial activation in fibromyalgia - A multi-site positron emission tomography investigation.Albrecht DS, Forsberg A, Sandström A et al. Brain Behav Immun, 2019.PubMedFull paper
- Systematic reviewAcute effects of physical exercises on the inflammatory markers of patients with fibromyalgia syndrome: A systematic review.Andrade A, Vilarino GT, Sieczkowska SM et al. J Neuroimmunol, 2018.PubMedFull paper
- Systematic reviewDietary Interventions in the Management of Fibromyalgia: A Systematic Review and Best-Evidence Synthesis.Lowry E, Marley J, McVeigh JG et al. Nutrients, 2020.PubMedFull paper
- Meta-analysisFibromyalgia and obesity: A comprehensive systematic review and meta-analysis.D'Onghia M, Ciaffi J, Lisi L et al. Semin Arthritis Rheum, 2021.PubMedFull paper
- Systematic reviewOral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults.Derry S, Wiffen PJ, Häuser W et al. Cochrane Database Syst Rev, 2017.PubMedFull paper
- Meta-analysisAerobic Exercise Prescription for Pain Reduction in Fibromyalgia: A Systematic Review and Meta-Analysis.Casanova-Rodríguez D, Ranchal-Sánchez A, Rodríguez RB et al. Eur J Pain, 2025.PubMedFull paper
